Statistics at a Glance
At a Glance
Breast, lung and bronchus, prostate, and colorectal cancers account for almost 50% of all new cancer cases in the United States. Lung and bronchus, colorectal, pancreatic, and breast cancers are responsible for nearly 50% of all deaths.
New Cancer Cases, 2020
Breast | 279,100 (15%) |
---|---|
Lung & Bronchus | 228,820 (13%) |
Prostate | 191,930 (11%) |
Colon and rectum | 147,950 (8%) |
Other | 958,790 (53%) |
Cancer Deaths, 2020
Lung & Bronchus | 135,720 (22%) |
---|---|
Colon and rectum | 53,200 (9%) |
Pancreas | 47,050 (8%) |
Breast | 42,690 (7%) |
Other | 327,860 (54%) |
How Many People Are Diagnosed with Cancer Each Year?
In 2020, roughly 1.8 million people will be diagnosed with cancer in the United States. An estimated 276,480 women and 2,620 men will be diagnosed with breast cancer, which makes it the most common cancer diagnosis. Lung and bronchus cancer is the second most common cancer diagnosis with an estimated 228,820 new cases. Prostate cancer is the leading cancer diagnosis among men and the third most common diagnosis overall with 191,930 expected cases.
The top 12 most common cancer sites, shown below, will account for more than three quarters of all new cancer cases.
Male
Breast | 2,620 |
---|---|
Lung & Bronchus | 116,300 |
Prostate | 191,930 |
Colorectal | 78,300 |
Melanoma of the Skin | 60,190 |
Urinary Bladder | 62,100 |
Non-Hodgkin Lymphoma | 42,380 |
Kidney and Renal Pelvis | 45,520 |
Uterus | 0 |
Leukemia | 35,470 |
Pancreas | 30,400 |
Thyroid | 12,720 |
Female
Breast | 276,480 |
---|---|
Lung & Bronchus | 112,520 |
Prostate | 0 |
Colorectal | 69,650 |
Melanoma of the Skin | 40,160 |
Urinary Bladder | 19,300 |
Non-Hodgkin Lymphoma | 34,860 |
Kidney and Renal Pelvis | 28,230 |
Corpus & Uterus, NOS | 65,620 |
Leukemia | 25,060 |
Pancreas | 27,200 |
Thyroid | 40,170 |
Source: Cancer Facts & Figures 2020, American Cancer Society (ACS), Atlanta, Georgia, 2020.
How Many People Die of Cancer Each Year?
In 2020, an estimated 606,520 people will die of cancer in the United States. Lung and bronchus cancer is responsible for the most deaths with 135,720 people expected to die from this disease. That is nearly three times the 53,200 deaths due to colorectal cancer, which is the second most common cause of cancer death. Pancreatic cancer is the third deadliest cancer, causing 47,050 deaths.
The eight deadliest cancer sites, shown below, will account for almost two-thirds of all expected cancer deaths.
Male
Lung and bronchus | 72,500 |
---|---|
Colon and rectum | 28,630 |
Pancreas | 24,640 |
Breast | 520 |
Liver & Intrahepatic Bile Duct | 20,020 |
Prostate | 33,330 |
Leukemia | 13,420 |
Non-Hodgkin Lymphoma | 11,460 |
Female
Lung and bronchus | 63,220 |
---|---|
Colon and rectum | 24,570 |
Pancreas | 22,410 |
Breast | 42,170 |
Liver & Intrahepatic Bile Duct | 10,140 |
Prostate | 0 |
Leukemia | 9,680 |
Non-Hodgkin Lymphoma | 8,480 |
Source: Cancer Facts & Figures 2020, American Cancer Society (ACS), Atlanta, Georgia, 2020.
New Cases, Deaths, and Survival
How Do Cancer Rates Compare?
For comparison purposes, new cases and deaths are generally expressed as a rate — the number per 100,000 in the total population. The rate of new cases is known as cancer incidence, and the death rate as mortality. Note that total population changes depending on what group you are looking at, so, for instance, the rate of new cases for females is the rate per 100,000 females in the U.S.
The table below gives the predicted number of new cases and deaths in 2020, the age-adjusted rate of new cases and deaths over the most recent five years of data, and the five-year relative survival rate, representing the percent surviving their cancer diagnosis 5-years after diagnosis.
You can sort on any column by clicking the header.
Site | Estimated New Cases (2020) | Rate of New Cases (2013–2017) | Estimated Deaths (2020) | Death Rate (2014–2018) | Relative Survival (%) (2010–2016) |
---|---|---|---|---|---|
Anus | 8,590 | 1.9 | 1,350 | 0.3 | 68.7 |
Bladder | 81,400 | 20.0 | 17,980 | 4.3 | 76.9 |
Bone and Joint | 3,600 | 1.0 | 1,720 | 0.5 | 66.0 |
Brain and Other Nervous System | 23,890 | 6.4 | 18,020 | 4.4 | 32.6 |
Breast | 279,100 | 68.9 | 42,690 | 11.1 | 90.0 |
Cervix Uteri | 13,800 | 7.4 | 4,290 | 2.2 | 66.1 |
Colon and Rectum | 147,950 | 38.2 | 53,200 | 13.7 | 64.6 |
Esophagus | 18,440 | 4.3 | 16,170 | 3.9 | 19.9 |
Hodgkin Lymphoma | 8,480 | 2.6 | 970 | 0.3 | 87.4 |
Kidney and Renal Pelvis | 73,750 | 16.3 | 14,830 | 3.6 | 75.2 |
Larynx | 12,370 | 2.9 | 3,750 | 0.9 | 60.6 |
Leukemia | 60,530 | 14.1 | 23,100 | 6.3 | 63.7 |
Liver and Intrahepatic Bile Duct | 42,810 | 9.0 | 30,160 | 6.6 | 19.6 |
Lung and Bronchus | 228,820 | 54.2 | 135,720 | 38.5 | 20.5 |
Melanoma of the Skin | 100,350 | 22.7 | 6,850 | 2.3 | 92.7 |
Myeloma | 32,270 | 7.0 | 12,830 | 3.2 | 53.9 |
Non-Hodgkin Lymphoma | 77,240 | 19.6 | 19,940 | 5.4 | 72.7 |
Oral Cavity and Pharynx | 53,260 | 11.4 | 10,750 | 2.5 | 66.2 |
Ovary | 21,750 | 11.2 | 13,940 | 6.7 | 48.6 |
Pancreas | 57,600 | 13.1 | 47,050 | 11.0 | 10.0 |
Prostate | 191,930 | 109.8 | 33,330 | 19.0 | 97.8 |
Small Intestine | 11,110 | 2.4 | 1,700 | 0.4 | 68.3 |
Stomach | 27,600 | 7.3 | 11,010 | 3.0 | 32.0 |
Testis | 9,610 | 5.9 | 440 | 0.3 | 95.0 |
Thyroid | 52,890 | 15.7 | 2,180 | 0.5 | 98.3 |
Uterus | 65,620 | 27.8 | 12,590 | 4.9 | 81.2 |
Vulva | 6,120 | 2.6 | 1,350 | 0.6 | 70.4 |
Site | Estimated New Cases (2020) | Rate of New Cases (2013–2017) | Estimated Deaths (2020) | Death Rate (2014–2018) | Relative Survival (%) (2010–2016) |
---|---|---|---|---|---|
Anus | 5,900 | 2.2 | 810 | 0.3 | 71.5 |
Bladder | 19,300 | 8.6 | 4,930 | 2.1 | 72.4 |
Bone and Joint | 1,480 | 0.8 | 720 | 0.4 | 68.7 |
Brain and Other Nervous System | 10,300 | 5.4 | 7,830 | 3.6 | 34.2 |
Breast | 276,480 | 128.5 | 42,170 | 20.1 | 90.0 |
Cervix Uteri | 13,800 | 7.4 | 4,290 | 2.2 | 66.1 |
Colon and Rectum | 69,650 | 33.6 | 24,570 | 11.5 | 65.1 |
Esophagus | 4,090 | 1.7 | 3,070 | 1.4 | 22.6 |
Hodgkin Lymphoma | 3,790 | 2.3 | 400 | 0.2 | 88.6 |
Kidney and Renal Pelvis | 28,230 | 11.1 | 4,970 | 2.3 | 76.3 |
Larynx | 2,550 | 1.1 | 750 | 0.4 | 57.6 |
Leukemia | 25,060 | 11.0 | 9,680 | 4.7 | 62.4 |
Liver and Intrahepatic Bile Duct | 12,640 | 4.8 | 10,140 | 4.0 | 20.5 |
Lung and Bronchus | 112,520 | 48.6 | 63,220 | 32.0 | 24.2 |
Melanoma of the Skin | 40,160 | 17.8 | 2,240 | 1.4 | 94.8 |
Myeloma | 14,740 | 5.7 | 5,640 | 2.6 | 54.1 |
Non-Hodgkin Lymphoma | 34,860 | 16.2 | 8,480 | 4.1 | 74.2 |
Oral Cavity and Pharynx | 14,880 | 6.4 | 2,990 | 1.3 | 67.7 |
Ovary | 21,750 | 11.2 | 13,940 | 6.7 | 48.6 |
Pancreas | 27,200 | 11.6 | 22,410 | 9.6 | 10.0 |
Prostate | - | - | - | - | - |
Small Intestine | 5,110 | 2.1 | 760 | 0.3 | 68.5 |
Stomach | 10,620 | 5.3 | 4,360 | 2.2 | 36.7 |
Testis | - | - | - | - | - |
Thyroid | 40,170 | 23.1 | 1,140 | 0.5 | 98.9 |
Uterus | 65,620 | 27.8 | 12,590 | 4.9 | 81.2 |
Vulva | 6,120 | 2.6 | 1,350 | 0.6 | 70.4 |
Site | Estimated New Cases (2020) | Rate of New Cases (2013–2017) | Estimated Deaths (2020) | Death Rate (2014–2018) | Relative Survival (%) (2010–2016) |
---|---|---|---|---|---|
Anus | 2,690 | 1.6 | 540 | 0.2 | 63.7 |
Bladder | 62,100 | 34.9 | 13,050 | 7.4 | 78.3 |
Bone and Joint | 2,120 | 1.1 | 1,000 | 0.6 | 63.8 |
Brain and Other Nervous System | 13,590 | 7.5 | 10,190 | 5.4 | 31.3 |
Breast | 2,620 | 1.2 | 520 | 0.3 | 83.6 |
Cervix Uteri | - | - | - | - | - |
Colon and Rectum | 78,300 | 43.7 | 28,630 | 16.3 | 64.0 |
Esophagus | 14,350 | 7.3 | 13,100 | 6.9 | 19.3 |
Hodgkin Lymphoma | 4,690 | 2.9 | 570 | 0.4 | 86.5 |
Kidney and Renal Pelvis | 45,520 | 22.4 | 9,860 | 5.3 | 74.5 |
Larynx | 9,820 | 5.0 | 3,000 | 1.7 | 61.3 |
Leukemia | 35,470 | 18.1 | 13,420 | 8.4 | 64.6 |
Liver and Intrahepatic Bile Duct | 30,170 | 13.8 | 20,020 | 9.7 | 19.3 |
Lung and Bronchus | 116,300 | 61.7 | 72,500 | 46.9 | 17.1 |
Melanoma of the Skin | 60,190 | 29.3 | 4,610 | 3.4 | 91.1 |
Myeloma | 17,530 | 8.8 | 7,190 | 4.1 | 53.7 |
Non-Hodgkin Lymphoma | 42,380 | 23.8 | 11,460 | 7.0 | 71.5 |
Oral Cavity and Pharynx | 38,380 | 17.2 | 7,760 | 3.9 | 65.6 |
Ovary | - | - | - | - | - |
Pancreas | 30,400 | 14.9 | 24,640 | 12.7 | 10.0 |
Prostate | 191,930 | 109.8 | 33,330 | 19.0 | 97.8 |
Small Intestine | 6,000 | 2.8 | 940 | 0.5 | 68.1 |
Stomach | 16,980 | 9.9 | 6,650 | 4.0 | 28.9 |
Testis | 9,610 | 5.9 | 440 | 0.3 | 95.0 |
Thyroid | 12,720 | 8.1 | 1,040 | 0.5 | 95.9 |
Uterus | - | - | - | - | - |
Vulva | - | - | - | - | - |
How Do the Most Common Cancers Compare by Race/Ethnicity?
The rate and type of cancer diagnosis varies significantly by race and ethnicity. The graph below shows the age-adjusted rate of new cases, by race and ethnicity, for the four most commonly diagnosed cancers.
Site | All Races | White | Black | API | AI/AN | Hispanic |
---|---|---|---|---|---|---|
Female Breast | 128.5 | 131.3 | 124.8 | 102.9 | 79.5 | 99.1 |
Colon and rectum | 38.2 | 37.8 | 43.6 | 31.8 | 39.0 | 33.7 |
Lung & Bronchus | 54.2 | 56.0 | 54.8 | 36.2 | 38.1 | 29.0 |
Prostate | 109.8 | 102.3 | 175.2 | 56.7 | 54.6 | 92.0 |
a Asian & Pacific Islander, b American Indian / Alaska Native
Age-adjusted rates of new cases, SEER 21, 2013–2017
Cancer death rates, or mortality rates, also vary significantly by race and ethnicity. The graph below shows the age-adjusted death rate, by race and ethnicity, for the five most commonly diagnosed cancers.
Site | All Races | White | Black | API | AI/AN | Hispanic |
---|---|---|---|---|---|---|
Female Breast | 20.1 | 19.6 | 27.3 | 11.7 | 14.8 | 13.8 |
Colon and rectum | 13.7 | 13.4 | 18.0 | 9.4 | 15.1 | 10.9 |
Lung & Bronchus | 38.5 | 39.3 | 40.1 | 21.2 | 32.1 | 16.8 |
Pancreas | 11.0 | 11.0 | 13.3 | 7.5 | 8.7 | 8.6 |
Prostate | 19.0 | 17.9 | 37.4 | 8.8 | 18.5 | 15.6 |
a Asian & Pacific Islander, b American Indian / Alaska Native
Age-adjusted death rates, U.S., 2014–2018
Trends in Rates
What Are the Recent Trends in Rates of New Cancer Cases?
Between 2013 and 2017, the overall age-adjusted rate of new cancers remained stable among men and remained stable among women. During this period, eight of the 19 most common cancers in men and eleven of the 21 most common cancers in women showed statistically significant decreases in new cases. For both men and women, laryngeal cancer showed the greatest decrease.
Trends In New Cases
Male
Melanoma of the Skin | 1.4* |
---|---|
Kidney and Renal Pelvis | 1.1* |
Prostate | 0.9 |
Pancreas | 0.9* |
Testis | 0.8* |
Oral Cavity and Pharynx | 0.7* |
Myeloma | 0.6 |
Liver and Intrahepatic Bile Duct | 0.4 |
Brain and Other Nervous System | -0.3* |
Thyroid | -0.6 |
All Sites | -0.6 |
Leukemia | -1.0 |
Non-Hodgkin Lymphoma | -1.2 |
Bladder | -1.3* |
Esophagus | -1.3* |
Stomach | -1.4* |
Colon and Rectum | -1.5* |
Hodgkin Lymphoma | -1.7* |
Lung and Bronchus | -2.3* |
Larynx | -3.6* |
Female
Melanoma of the Skin | 1.6* |
---|---|
Myeloma | 1.2* |
Uterus | 1.2* |
Liver and Intrahepatic Bile Duct | 1.0 |
Pancreas | 0.8* |
Kidney and Renal Pelvis | 0.7* |
Cervix Uteri | 0.5 |
Breast | 0.4* |
Oral Cavity and Pharynx | 0.3* |
All Sites | 0.0 |
Leukemia | -0.1 |
Non-Hodgkin Lymphoma | -0.4* |
Brain and Other Nervous System | -0.4* |
Stomach | -0.6* |
Bladder | -1.0* |
Lung and Bronchus | -1.0* |
Colon and Rectum | -1.0* |
Hodgkin Lymphoma | -1.1* |
Ovary | -1.6* |
Esophagus | -1.6* |
Thyroid | -1.9* |
Larynx | -2.3* |
What Are the Recent Trends in Cancer Death Rates?
Between 2014 and 2018, overall age-adjusted death rate decreased on average 2.2 percent per year for men and 1.7 percent for women. During this period, twelve of the 19 most common cancers in men and fifteen of the 21 most common cancers in women showed statistically significant decreases in death rates. Thyroid cancer showed the greatest increase in death rates among men. Uterine cancer showed the greatest increase in death rates among women.
Trends In Death Rates
Male
Thyroid | 0.9* |
---|---|
Oral Cavity and Pharynx | 0.6* |
Liver and Intrahepatic Bile Duct | 0.4 |
Brain and Other Nervous System | 0.4* |
Pancreas | 0.3* |
Testis | 0.0 |
Prostate | -0.4 |
Myeloma | -0.9* |
Bladder | -1.3* |
Non-Hodgkin Lymphoma | -1.9* |
Esophagus | -1.9* |
Colon and Rectum | -1.9* |
Leukemia | -2.1* |
All Sites | -2.2* |
Kidney and Renal Pelvis | -2.4* |
Stomach | -2.5* |
Larynx | -2.5* |
Hodgkin Lymphoma | -2.9* |
Lung and Bronchus | -5.2* |
Melanoma of the Skin | -5.7* |
Female
Uterus | 2.0* |
---|---|
Liver and Intrahepatic Bile Duct | 1.1* |
Brain and Other Nervous System | 0.4* |
Thyroid | 0.2 |
Pancreas | 0.2* |
Oral Cavity and Pharynx | -0.1 |
Bladder | -0.6* |
Cervix Uteri | -0.7* |
Breast | -1.0* |
Leukemia | -1.4* |
Kidney and Renal Pelvis | -1.4* |
Esophagus | -1.6* |
All Sites | -1.7* |
Stomach | -1.9* |
Myeloma | -1.9* |
Colon and Rectum | -2.0* |
Ovary | -2.3* |
Larynx | -2.4* |
Non-Hodgkin Lymphoma | -2.7* |
Lung and Bronchus | -4.3* |
Melanoma of the Skin | -4.3* |
Hodgkin Lymphoma | -4.9* |
Additional Information
Average annual percent change (AAPC) is the year-to-year change averaged over a period of time, in this case, 5 years. Positive AAPC describes an increasing trend and a negative AAPC a decreasing one.
Cancer in Context
How Does Cancer Compare to Other Causes of Death?
Cancer caused 21.1% of all deaths in the United States in 2018. Deaths due to heart disease and cancer caused nearly half of all deaths in the United States. Cancer is the leading cause of death for those under 65 years of age.
Leading Causes of Death in the U.S., 2018
Heart Disease | 655,341 |
---|---|
Cancer | 599,265 |
Chronic Lower Respiratory | 159,481 |
Accidents (Unintentional Injury) | 167,107 |
Stroke (Cerebrovascular) | 147,809 |
Alzheimer's | 122,018 |
Diabetes | 84,940 |
Pneumonia & Influenze | 59,118 |
Nephritis & Nephrosis | 51,383 |
Intentional Self-Harm (Suicide) | 48,344 |
What Are the U.S. Death Rates?
In the United States, heart disease death rates have decreased for people of all ages. In 1975, heart disease among those less than 65 caused 26% of deaths, compared to 17% in 2018. In those over 65, heart disease caused 44% of deaths in 1975, compared to 25% in 2018.
Neoplasms have slightly increased for people of all ages. In 1975, neoplasms for those less than 65 accounted for 22% of deaths in the United States, compared to 23% in 2018. In those over 65, neoplasms caused 18% of deaths in 1975, compared to 21% in 2018.
Ages <65
Year | Heart Disease | Cancer | ||
---|---|---|---|---|
Rate Per 100,000 | % of Total Deaths | Rate Per 100,000 | % of Total Deaths | |
1975 | 98.6 | 26 | 84.0 | 22 |
1976 | 95.9 | 26 | 84.3 | 23 |
1977 | 92.6 | 26 | 84.3 | 23 |
1978 | 90.4 | 26 | 84.2 | 24 |
1979 | 88.3 | 26 | 83.3 | 24 |
1980 | 86.9 | 26 | 83.7 | 24 |
1981 | 84.9 | 26 | 82.8 | 25 |
1982 | 82.0 | 26 | 83.0 | 26 |
1983 | 80.7 | 26 | 82.7 | 26 |
1984 | 78.3 | 25 | 83.3 | 26 |
1985 | 76.6 | 25 | 83.2 | 26 |
1986 | 74.0 | 24 | 82.2 | 26 |
1987 | 71.5 | 23 | 81.7 | 26 |
1988 | 69.1 | 22 | 81.3 | 26 |
1989 | 65.1 | 21 | 80.5 | 26 |
1990 | 62.4 | 21 | 80.1 | 26 |
1991 | 61.0 | 20 | 79.2 | 26 |
1992 | 59.7 | 20 | 77.4 | 26 |
1993 | 59.5 | 20 | 76.2 | 26 |
1994 | 57.8 | 20 | 75.0 | 26 |
1995 | 56.9 | 20 | 73.4 | 25 |
1996 | 55.5 | 20 | 71.7 | 26 |
1997 | 53.4 | 21 | 69.7 | 27 |
1998 | 51.4 | 20 | 67.9 | 27 |
1999 | 49.4 | 20 | 66.9 | 27 |
2000 | 47.7 | 19 | 65.5 | 27 |
2001 | 46.6 | 19 | 64.9 | 26 |
2002 | 46.3 | 19 | 63.7 | 26 |
2003 | 45.3 | 19 | 62.3 | 26 |
2004 | 43.1 | 19 | 60.4 | 26 |
2005 | 42.6 | 18 | 59.7 | 26 |
2006 | 41.5 | 18 | 58.5 | 26 |
2007 | 40.0 | 18 | 56.9 | 26 |
2008 | 39.5 | 18 | 55.8 | 26 |
2009 | 38.3 | 18 | 55.3 | 26 |
2010 | 37.4 | 18 | 54.2 | 27 |
2011 | 37.1 | 18 | 53.4 | 26 |
2012 | 36.9 | 18 | 53.0 | 26 |
2013 | 36.9 | 18 | 52.0 | 26 |
2014 | 37.1 | 18 | 51.5 | 25 |
2015 | 37.3 | 18 | 50.5 | 25 |
2016 | 37.4 | 17 | 49.7 | 24 |
2017 | 37.2 | 17 | 48.3 | 23 |
2018 | 37.2 | 17 | 47.2 | 23 |
Ages 65+
Year | Heart Disease | Cancer | ||
---|---|---|---|---|
Rate Per 100,000 | % of Total Deaths | Rate Per 100,000 | % of Total Deaths | |
1975 | 2734.9 | 44 | 995.2 | 18 |
1976 | 2747.4 | 44 | 1018.3 | 18 |
1977 | 2656.3 | 44 | 1023.3 | 19 |
1978 | 2643.2 | 44 | 1035.4 | 19 |
1979 | 2595.8 | 45 | 1042.7 | 19 |
1980 | 2652.4 | 44 | 1059.1 | 19 |
1981 | 2568.9 | 44 | 1060.7 | 20 |
1982 | 2524.7 | 44 | 1074.6 | 20 |
1983 | 2532.4 | 44 | 1083.5 | 20 |
1984 | 2468.6 | 43 | 1093.0 | 20 |
1985 | 2449.2 | 42 | 1097.2 | 20 |
1986 | 2389.6 | 42 | 1107.5 | 21 |
1987 | 2333.4 | 41 | 1111.8 | 21 |
1988 | 2321.1 | 40 | 1120.3 | 21 |
1989 | 2184.9 | 39 | 1139.1 | 22 |
1990 | 2102.7 | 39 | 1147.4 | 22 |
1991 | 2054.6 | 38 | 1154.0 | 23 |
1992 | 1995.9 | 38 | 1153.7 | 23 |
1993 | 2027.9 | 37 | 1161.8 | 22 |
1994 | 1954.3 | 37 | 1157.0 | 23 |
1995 | 1927.5 | 36 | 1153.6 | 22 |
1996 | 1878.5 | 36 | 1142.2 | 22 |
1997 | 1828.4 | 35 | 1128.5 | 22 |
1998 | 1791.7 | 35 | 1119.6 | 22 |
1999 | 1766.3 | 34 | 1125.9 | 22 |
2000 | 1698.3 | 33 | 1119.8 | 22 |
2001 | 1648.2 | 32 | 1104.4 | 22 |
2002 | 1611.1 | 32 | 1097.2 | 22 |
2003 | 1551.7 | 31 | 1079.7 | 22 |
2004 | 1449.7 | 30 | 1060.8 | 22 |
2005 | 1415.4 | 30 | 1053.2 | 22 |
2006 | 1333.7 | 29 | 1036.1 | 22 |
2007 | 1268.7 | 28 | 1025.1 | 22 |
2008 | 1240.5 | 28 | 1009.5 | 22 |
2009 | 1174.6 | 27 | 989.8 | 22 |
2010 | 1143.6 | 27 | 984.1 | 22 |
2011 | 1114.1 | 26 | 966.2 | 22 |
2012 | 1089.0 | 26 | 950.5 | 22 |
2013 | 1086.2 | 26 | 932.9 | 21 |
2014 | 1064.2 | 25 | 921.3 | 22 |
2015 | 1076.8 | 25 | 908.2 | 21 |
2016 | 1051.4 | 25 | 891.0 | 21 |
2017 | 1049.6 | 25 | 873.9 | 21 |
2018 | 1037.9 | 25 | 853.3 | 21 |
Interactive Statistics with SEER*Explorer
With SEER*Explorer, you can...
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Explore Additional Cancer Statistics
More About Cancer Surveillance
More Information
Here are some resources for learning more about cancer surveillance:
- For more information about the Surveillance, Epidemiology, and End Results (SEER) Program, visit https://seer.cancer.gov/.
- The State Cancer Profiles website provides dynamic views of cancer statistics for prioritizing cancer control efforts in the nation, states, and counties.
- The Know Your Chances website presents interactive risk charts to put probabilities (risk) of dying from cancer and other diseases in context.
- The Cancer Statistics Animator is a tool that allows users to animate cancer trends over time by cancer site and cause of death, race, and sex.
- The Cancer Prevalence and Cost of Care Projections website shows data for cancer prevalence estimated and projected by tumor site through 2020.
- For more information about SEER's interactive tools, visit https://seer.cancer.gov/statistics/interactive.html.
- The American Cancer Society's Cancer Statistics Center website is a comprehensive interactive resource for learning about the cancer burden in the United States.
- For information about the National Program of Cancer Registries, visit https://www.cdc.gov/cancer/npcr/.
- For more information about Cancer Data and Statistics, visit https://www.cdc.gov/cancer/dcpc/data/.
- For more Cancer Data and Statistics Tools, visit https://www.cdc.gov/cancer/dcpc/data/tools.htm.
- Learn more about Cancer Surveillance Programs in the United States by visiting https://www.cancer.org/cancer/cancer-basics/cancer-surveillance-programs-and-registries-in-the-united-states.html.
References
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Statistics Factsheets: Common Cancer Sites. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/common.html
- Create custom graphs and tables
- Download data and images
- Share links to results
SEER*Explorer is an interactive website that provides easy access to a wide range of SEER cancer statistics. It provides detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number of cancer sites, by stage and histology.
Explore Additional Cancer StatisticsMore Information
Here are some resources for learning more about cancer surveillance:
- For more information about the Surveillance, Epidemiology, and End Results (SEER) Program, visit https://seer.cancer.gov/.
- The State Cancer Profiles website provides dynamic views of cancer statistics for prioritizing cancer control efforts in the nation, states, and counties.
- The Know Your Chances website presents interactive risk charts to put probabilities (risk) of dying from cancer and other diseases in context.
- The Cancer Statistics Animator is a tool that allows users to animate cancer trends over time by cancer site and cause of death, race, and sex.
- The Cancer Prevalence and Cost of Care Projections website shows data for cancer prevalence estimated and projected by tumor site through 2020.
- For more information about SEER's interactive tools, visit https://seer.cancer.gov/statistics/interactive.html.
- The American Cancer Society's Cancer Statistics Center website is a comprehensive interactive resource for learning about the cancer burden in the United States.
- For information about the National Program of Cancer Registries, visit https://www.cdc.gov/cancer/npcr/.
- For more information about Cancer Data and Statistics, visit https://www.cdc.gov/cancer/dcpc/data/.
- For more Cancer Data and Statistics Tools, visit https://www.cdc.gov/cancer/dcpc/data/tools.htm.
- Learn more about Cancer Surveillance Programs in the United States by visiting https://www.cancer.org/cancer/cancer-basics/cancer-surveillance-programs-and-registries-in-the-united-states.html.
References
All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within SEER*Explorer.
Estimates of new cases and deaths for 2020 are projections made by the American Cancer Society (ACS), based on earlier reported data.
Suggested Citation
All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.
SEER Cancer Statistics Factsheets: Common Cancer Sites. National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/statfacts/html/common.html